The FDA cleared da Vinci SP for use in inguinal hernia repair, cholecystectomy and appendectomy procedures. These clearances add to existing U.S. indications in urology, colorectal, thoracic and transoral procedures. They also mark the second label expansion from the FDA this year, with da Vinci SP picking up clearance for transanal local excision/resection in colorectal procedures in May.

“Da Vinci SP was designed to give surgeons advanced capability through a single port, offering the precision and control needed in narrow or deep anatomical spaces,” said Iman Jeddi, SVP and General Manager, da Vinci Platforms and Product Operations at Intuitive. “This clearance is one part of our innovation pathway for SP. We continue to evolve the platform with new tools and capabilities that help teams pursue less invasive approaches and expand what’s possible with da Vinci SP.”